Fisher & Paykel Healthcare Corporation Limited
FSPKF
$16.93
-$1.99-10.50%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Revenue | 10.45% | 9.13% | 7.79% | 8.80% | 7.02% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 10.45% | 9.13% | 7.79% | 8.80% | 7.02% |
Cost of Revenue | 7.74% | 7.01% | 6.28% | 9.88% | 10.77% |
Gross Profit | 12.28% | 10.58% | 8.83% | 8.09% | 4.63% |
SG&A Expenses | 9.74% | 10.59% | 11.51% | 10.62% | 7.07% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 9.03% | 8.88% | 8.76% | 10.23% | 8.98% |
Operating Income | 15.75% | 10.07% | 4.16% | 3.66% | 0.30% |
Income Before Tax | -15.82% | -22.61% | -29.52% | -11.46% | 2.97% |
Income Tax Expenses | 31.36% | 30.64% | 30.30% | 31.28% | 27.84% |
Earnings from Continuing Operations | -32.52% | -40.33% | -48.02% | -23.71% | -3.66% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -32.52% | -40.33% | -48.02% | -23.71% | -3.66% |
EBIT | 15.75% | 10.07% | 4.16% | 3.66% | 0.30% |
EBITDA | 17.87% | 12.19% | 6.27% | 4.44% | -0.05% |
EPS Basic | -33.11% | -40.78% | -48.29% | -24.01% | -4.04% |
Normalized Basic EPS | 10.69% | 4.98% | -0.91% | 2.43% | 2.58% |
EPS Diluted | -33.33% | -40.86% | -48.30% | -23.99% | -4.00% |
Normalized Diluted EPS | 10.54% | 4.83% | -1.05% | 2.26% | 2.46% |
Average Basic Shares Outstanding | 0.77% | 0.72% | 0.66% | 0.53% | 0.40% |
Average Diluted Shares Outstanding | 0.85% | 0.82% | 0.78% | 0.67% | 0.57% |
Dividend Per Share | 1.43% | 0.84% | 0.24% | -1.05% | -4.87% |
Payout Ratio | 0.39% | 0.33% | 0.31% | -0.16% | -0.37% |